Early data suggests an AI-developed drug could slow aging
Dr_Singularity · x · 2026-09-07
A brief repost of the Rentosertib story: the AI-assisted drug candidate, originally developed for a rare lung condition, also seems to reduce biological hallmarks of age, according to its maker Insilico Medicine.
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Research
- rauchg reproduces OpenAI's covert CPU-channel finding: chat across Firecracker microVMs with no network — ccerrato147 · 2026-10-27
- Microsoft Research: ForkPilot cuts long-horizon agent compute by up to 59% — EliasEskin · 2026-10-27
- Microsoft's TeleTune evolves agent skills from offline user telemetry — EliasEskin · 2026-10-27
- FlexGlue: sparse-to-dense matching that beats dense accuracy at a fraction of the cost — zhenjun_zhao · 2026-10-27
- Mundo turns a few room photos into an explorable, simulatable 3D world — at 1.5 FPS — mark_k · 2026-10-27
- Mathematics as an experimental science: Marc Lelarge to talk LLM-driven math experiments at ENS — marc_lelarge · 2026-10-27